NYSE:RY - New York Stock Exchange, Inc. - CA7800871021 - Common Stock - Currency: USD
Roth Capital lowered the firm’s price target on Shopify (SHOP) to $115 from $136 and keeps a Buy rating on the shares. The firm’s Q1 merchant checks suggest 21% year-over-year average growth, below Roth’s 25% gross merchandise volume growth estimate. However, Shopify has outperformed Roth’s survey work by 590 basis points the last four quarters, the analyst tells investors in a research note. Nonetheless, Roth says its merchant checks suggest some consumer softness trends in second half of March
Google stock climbed on better-than-expected Q1 earnings and search ad revenue as management touted the new AI Overviews format.
BMO Capital lowered the firm’s price target on Masco (MAS) to $65 from $75 and keeps a Market Perform rating on the shares. The stock is likely to remain range bound in the near-term due to uncertainty around tariffs, the analyst tells investors in a research note. While the balance sheet is healthy, price hikes to mitigate the tariff drag puts further downward pressure on demand, and the case to buy the stock today isn’t obvious against the backdrop of weakening demand and tariffs, the firm say
Scotiabank raised the firm’s price target on AT&T to $29.50 from $29 and keeps an Outperform rating on the shares. The company continues to deliver steady growth supported by a balanced subscriber loading go to market strategy, the analyst tells investors. The firm is increasing its price target due to a slight increase in its medium-term growth assumptions on wireless and consumer segments. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try
Stock futures were lower on Friday following a three-day winning streak.
Here are the biggest calls on Wall Street on Friday.
Consumer goods giant P&G on Thursday reported quarterly earnings that beat estimates, but revenue that disappointed, leading shares lower.
Mentions: RY.CA
China’s government is considering suspending its 125% tariff on some US imports, people familiar with the matter said, as the economic costs of the tit-for-tat trade war weigh heavily on certain industries. Authorities are considering removing the additional levies for medical equipment and some industrial chemicals like ethane, the people said, asking not to be identified discussing private deliberations. Meanwhile President Donald Trump said his administration was talking with China on trade, after Beijing denied the existence of negotiations on a deal and demanded the US revoke all unilateral tariffs. Today's guests: Leila Benali, Moroccan Minister of Energy Transition & Sustainable Development, Maria Municchi, M&G Investments Fund Manager, Amy Gower, Morgan Stanley Metals & Mining Commodities Strategist, Anke Reingen, RBC Capital Markets Co-Head of Global Financials Research. (Source: Bloomberg)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at RBC Bearings (NYSE:RBC) and the best and worst performers in the engineered components and systems industry.
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Ann Berry, Threadneedle Ventures, Chris Wright, US Energy Secretary, Nik Modi, RBC Capital Markets, Andrea Guerzoni, EY-Parthenon, Lindsay Dutch, Bloomberg Intelligence, Sinead Colton Grant, BNY Wealth, Ed Ludlow, Bloomberg News, Matt Bryson, Wedbush, Brent Thill, Jefferies, Abigail Gilmartin, Bloomberg Intelligence, Mark Zagorski, DoubleVerify, Mozelle Thompson, UBME Inc., Sarah Frier, Bloomberg News. (Source: Bloomberg)
Fed independence brings stability, and markets love stability.
Pharming (PHAR) Group announced overnight that the National Institute for Health and Care Excellence has issued positive final guidance recommending Joenja for reimbursement and use within the National Health Service in England and Wales for the treatment of activated phosphoinositide 3-kinase delta syndrome in adult and pediatric patients 12 years of age and older. The company says Joenja is now available for use and funded in England through the Innovative Medicines Fund. In Wales, Joenja is e
Jefferies lowered the firm’s price target on Enphase Energy (ENPH) to $37 from $44 and keeps an Underperform rating on the shares after the company missed Q1 expectations and guided to a tariff impact on gross margins that is expected to last through Q2 of 2026. The firm continues to view the backdrop as challenging, with tariffs “just throwing another wrench into the story,” the analyst tells investors. Published first on TheFly – the ultimate source for real-time, market-moving breaking financ
RBC Capital lowered the firm’s price target on Hexcel (HXL) to $62 from $70 and keeps an Outperform rating on the shares. The company reported a soft Q1 with a 3% sales decline, and the management also lowered its 2025 guidance, now reflecting basically flat growth across its end markets, the analyst tells investors in a research note. Hexcel’s focus on better cost control is a positive, and the stock’s valuation is compelling for the potential 2026-2028 upside, the firm adds. Published first on
We recently published an article titled These 10 Firms Led Lagged Performance on Wednesday. In this article, we are going to take a look at where Enphase Energy, Inc. (NASDAQ:ENPH) stands against the other stocks. Wall Street’s major indices finished in the green territory anew on Wednesday as worries about tariff policies and the Federal Reserve’s […]